BioMarin Pharmaceutical Inc.
BMRN
$66.05
$0.981.50%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -60.67% | 42.41% | 5.60% | 3.19% | 12.56% |
| Total Receivables | 17.38% | -0.47% | 14.93% | -7.66% | 15.78% |
| Inventory | 40.00% | -1.98% | -6.03% | 3.13% | 5.12% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 23.62% | 10.61% | -9.05% | 15.28% | -2.40% |
| Total Current Assets | -13.76% | 16.48% | 2.57% | 1.29% | 9.73% |
|
|
|||||
| Total Current Assets | -13.76% | 16.48% | 2.57% | 1.29% | 9.73% |
| Net Property, Plant & Equipment | 3.33% | -3.40% | -4.47% | 0.76% | -0.22% |
| Long-term Investments | 234.22% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 234.22% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | 2,284.11% | -34.16% | 33.34% | -2.72% | -3.12% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -53.30% | 59.27% | -7.33% | 6.19% | -1.18% |
| Total Assets | 36.46% | 13.13% | -0.27% | 2.13% | 4.33% |
|
|
|||||
| Total Accounts Payable | 2.91% | 26.44% | -19.74% | 25.38% | 5.80% |
| Total Accrued Expenses | 52.05% | -12.16% | 21.42% | 11.76% | 5.03% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7,135.34% | 7.30% | 14.61% | -1.64% | 22.11% |
| Total Finance Division Other Current Liabilities | 33.62% | -2.96% | -43.40% | 1.71% | 45.99% |
| Total Other Current Liabilities | 33.62% | -2.96% | -43.40% | 1.71% | 45.99% |
| Total Current Liabilities | 109.80% | 4.50% | -4.94% | 16.69% | 8.92% |
|
|
|||||
| Total Current Liabilities | 109.80% | 4.50% | -4.94% | 16.69% | 8.92% |
| Long-Term Debt | 146.66% | 139.51% | 0.09% | 0.08% | 0.09% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 34.95% | 36.62% | -30.21% | 9.57% | 14.75% |
| Total Liabilities | 127.07% | 57.85% | -3.28% | 9.02% | 5.59% |
|
|
|||||
| Common Stock & APIC | 1.18% | 0.17% | 0.94% | 0.84% | 0.99% |
| Retained Earnings | 17.23% | 68.43% | -23.20% | -13.28% | 2,669.91% |
| Treasury Stock & Other | -36.28% | 38.76% | 46.98% | 19.58% | -805.28% |
| Total Common Equity | 1.76% | 2.06% | 0.50% | 0.49% | 4.03% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.76% | 2.06% | 0.50% | 0.49% | 4.03% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.76% | 2.06% | 0.50% | 0.49% | 4.03% |
|
|
|||||